SIRRESTA Trademark

Trademark Overview

On Tuesday, June 16, 2015, a trademark application was filed for SIRRESTA with the United States Patent and Trademark Office. The USPTO has given the SIRRESTA trademark a serial number of 86663734. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 15, 2018. This trademark is owned by Glaxo Group Limited. The SIRRESTA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Study, research and development in the field of medicines, conducting clinical trials
sirresta

General Information

Serial Number86663734
Word MarkSIRRESTA
Filing DateTuesday, June 16, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 15, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 20, 2015

Trademark Statements

Goods and ServicesStudy, research and development in the field of medicines, conducting clinical trials
Translation of Words in MarkThe wording "SIRRESTA" has no meaning in a foreign language.

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, June 19, 2015
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Tuesday, January 16, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 15, 2018ABANDONMENT - NO USE STATEMENT FILED
Friday, June 16, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 14, 2017EXTENSION 3 GRANTED
Wednesday, June 14, 2017EXTENSION 3 FILED
Wednesday, June 14, 2017TEAS EXTENSION RECEIVED
Tuesday, January 10, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, January 7, 2017EXTENSION 2 GRANTED
Thursday, December 8, 2016EXTENSION 2 FILED
Thursday, January 5, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 8, 2016TEAS EXTENSION RECEIVED
Thursday, May 26, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 24, 2016EXTENSION 1 GRANTED
Tuesday, May 24, 2016EXTENSION 1 FILED
Tuesday, May 24, 2016TEAS EXTENSION RECEIVED
Tuesday, December 15, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 20, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 20, 2015PUBLISHED FOR OPPOSITION
Wednesday, September 30, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, September 13, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 11, 2015ASSIGNED TO EXAMINER
Friday, June 19, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 19, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

sirresta conducting clinical trials medicines field research development study